Personalised medicine: promotion of solutions, strategies and best practices for implementation during the ICPerMed online conference on 25 and 26 February 2021

Centred on the characteristics of individuals (genomic data, information on lifestyle, etc.) personalised medicine aims to improve the efficiency of diagnostics, treatments and preventive measures, for the benefit of patients and citizens. What are the challenges and the existing solutions for its implementation? This key question, particularly with regard to the Covid-19 pandemic, is at the heart of the online conference organised on 25 and 26 February 2021 by ICPerMed, with the support of the European Commission and ANR. Registrations are open until 26 February 2021.

Personalised medicine: the next generation medicine by 2030

ICPerMed, an international consortium on personalised medicine bringing together more than 40 European and international partners including ANR, has analysed the needs of stakeholders in the field over recent years, thus identifying 5 main challenges and levers of action for the implementation of personalised medicine. These are detailed in a Vision Paper published in 2019.

On the basis of this strategic document, the ICPerMed “Personalised medicine - From vision to practice” conference will be structured around 5 sessions during which speakers will present courses of action for:

  • Health democracy and the inclusion of patients' and citizens' preferences;
  • Strengthening data harmonisation for better use;
  • Integration of personalised medicine into health systems;
  • Creation of an efficient entrepreneurial ecosystem between academy and industry in order to stimulate innovation in health;
  • Redefining the notion of value in healthcare by incorporating patient preferences and socio-economic aspects.

A session will also be dedicated to lessons learned from the Covid-19 pandemic and the contribution of personalised medicine in the fight against infectious diseases. Furthermore, ICPerMed will feature and honour best practices in personalised medicine research through the ICPerMed Recognition 2020, aiming to recognise, encourage, promote and disseminate outstanding examples.

The conference will bring together world-renowned researchers, experts in ELSA (ethical, legal and social aspects), health economists, patients and representatives from industry, regulatory authorities, and members of ICPerMed, including representatives of ministries, research funding agencies and policy makers.

View the full programme of the ICPerMed conference

Speaker biographies

Register for the conference via this link

ANR's involvement in international personalised medicine research and collaboration programmes

The French National Research Agency (ANR) is a member of the ICPerMed consortium alongside the Ministry of Higher Education, Research and Innovation. It is also involved in the CSA ICPerMed Secretariat (2016-2021), in the CSA EU-Africa PerMed aimed at the integration of African countries in ICPerMed discussions, and in the ERA-NET ERA PerMed. In the context of these partnerships, it participates in discussions on the international coordination of research in the field, finances transnational projects and encourages interdisciplinary collaborations for the implementation of personalised medicine.


The International Consortium of Personalised Medicine (ICPerMed) is a platform created in November 2016 which brings together more than 40 European and international partners representing ministries, funding agencies and the European Commission. The goal of ICPerMed is to stimulate personalised medicine by strengthening the coordination and alignment of research activities. ICPerMed website

Sign up for the latest news:
Subscribe to our newsletter